Memorial Sloan-Kettering’s new research complex contains more than 100 laboratories, nearly doubling the space we dedicate to research to better understand and treat cancer.

Good Morning America co-host Robin Roberts recently said good-bye to her inpatient treatment team at Memorial Sloan-Kettering after undergoing a stem cell transplant to treat myelodysplastic syndrome.

Researchers have produced a fully synthetic, functional version of erythropoietin, the hormone that controls production of red blood cells.

About Herbs, presented by Memorial Sloan-Kettering’s Integrative Medicine Service, gives mobile device users a comprehensive guide to botanicals, supplements, complementary therapies, and more.

A new program is training nurses across the country to identify the needs of cancer survivors and to help patients and their families achieve the best possible quality of life after treatment.

Dr. Gany works to identify the causes of health disparities in underserved communities, and to develop ways to more effectively deliver care to ethnically diverse populations.

Memorial Sloan-Kettering researchers have discovered a way that cancer cells may be able to exchange information by establishing long bridges between cells called tunneling nanotubes.